Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/ORYZON-GENOMICS-S-A-25531377/actualite/Oryzon-annonce-le-premier-patient-de-Frida-un-essai-de-phase-Ib-avec-Iadademstat-chez-des-patients-43271214/?utm_source=whatsapp&utm_medium=social&utm_campaign=share